Biotech Revolutrion with seRNA
SRTD biotech is a German company that has set itself the goal of developing a revolutionary treatment method using seRNAs. This first pro-drug technology at the RNA level targets various oncological, genetic and viral diseases.
seRNA for a new era of therapy
Many life-threatening diseases cannot yet be treated effectively. Even when therapies do exist, they too often do not specifically target the diseased area, leading to a high risk of severe side effects. To overcome this fundamental problem, SRTD biotech has developed seRNA (selectively expressed RNA) as a new therapeutic approach.
A broad Field of Applications opens up
seRNA enables the development of an innovative platform technology for the treatment of cancer, viral and genetic diseases that works exactly - and only - where it is supposed to.
SRTD biotech has set itself ambitious goals in the development pipeline, which it intends to realize together with its investors.
Services provided for the client
- Corporate design development
- UX conception
- UX design
- Frontend development
- CMS implementation (Wordpress)
Weitere Projekte
